Assessment of two glycated hemoglobin immunoassays

Guariguata, 2014, Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabetes Res Clin Pract, 103, 137, 10.1016/j.diabres.2013.11.002 2017, 76 Shapiro, 1980, Sites of nonenzymatic glycosylation of human hemoglobin A, J Biol Chem, 255, 3120, 10.1016/S0021-9258(19)85860-X Trivelli, 1971, Hemoglobin components in patients with diabetes mellitus, N Engl J Med, 284, 353, 10.1056/NEJM197102182840703 Bunn, 1976, The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo, J Clin Invest, 57, 1652, 10.1172/JCI108436 Rahbar, 2005, The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems, Ann N Y Acad Sci, 1043, 9, 10.1196/annals.1333.002 Rahbar, 1969, Hemoglobin studies of the unusual hemoglobin in patients with diabetes mellitus, Biochem Biophys Res Commun, 36, 838, 10.1016/0006-291X(69)90685-8 Nathan, 2008, Diabetes Care, 31, 1473, 10.2337/dc08-0545 Saudek, 2008, A new look at screening and diagnosing diabetes mellitus, J Clin Endocrinol Metab, 93, 2447, 10.1210/jc.2007-2174 International Expert Committee, 2009, International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care, 32, 1327, 10.2337/dc09-9033 2011, Report of a World Health Organization Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus, Diabetes Res Clin Pract, 93, 299, 10.1016/j.diabres.2011.03.012 Lenters-Westra, 2013, Haemoglobin A1c: historical overview and current concepts, Diabetes Res Clin Pract, 99, 75, 10.1016/j.diabres.2012.10.007 Weycamp, 2013, HbA1c: a review of analytical and clinical aspects, Ann Lab Med, 33, 393, 10.3343/alm.2013.33.6.393 2018, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018, Diabetes Care, 41, S13, 10.2337/dc18-S002 Gomez-Peralta, 2018, Recomendaciones de la Sociedad Española de Diabetes (SED) para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2: Actualización 2018, Endocrinol Diabetes Nutr, 65, 611, 10.1016/j.endinu.2018.08.004 2018, Glycemic targets: standards of medical care in diabetes-2018, Diabetes Care, 4, S55 Nathan, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Forbes, 2018, Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study, Lancet Diabetes Endocrinol, 6, 476, 10.1016/S2213-8587(18)30048-2 Donnelly, 2018, Rates of glycaemic deterioration in a real-world population with type 2 diabetes, Diabetologia, 61, 607, 10.1007/s00125-017-4519-5 Little, 2011, National Glycohemoglobin Standardization Program (NGSP) Steering Committee. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care, Clin Chem, 7, 205, 10.1373/clinchem.2010.148841 Cercado, 2017, Hemoglobin A1c, diabetes mellitus, diabetic nephropathy and chronic kidney disease, Nefrol Dial Traspl, 37, 225 Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurements, Lancet, 1, 307, 10.1016/S0140-6736(86)90837-8 Bahar, 2017, An interactive website for analytical method comparison and bias estimation, Clin Biochem, 50, 1025, 10.1016/j.clinbiochem.2017.08.008 National Glycohemoglobin Standardization Program. Convert between NGSP, IFCC and eAG. Available from: http://www.ngsp.org/convert2.asp [accessed 08-25-19]. Flood, 2017, A home-based type 2 diabetes self-management intervention in rural Guatemala, Prev Chronic Dis, 14, E65, 10.5888/pcd14.170052 National Glycohemoglobin Standardization Program, 2019 National Glycohemoglobin Standardization Program, 2019 Lenters-Westra, 2009, Hemoglobin A1c point-of-care assays; a new world with a lot of consequences!, J Diabetes Sci Technol, 3, 418, 10.1177/193229680900300303 Lenters-Westra, 2014, Three of 7 Hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria, Clin Chem, 60, 1062, 10.1373/clinchem.2014.224311